News
(Reuters) -British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to ...
Needle mushrooms and other mushroom products are impacted by two separate recall notices from the Food and Drug ...
While the complete response letter derails a near-term clearance, one analyst described the rejection as more of “a speed ...
The manufacturing-related rejection for UX111 is more than a setback for Ultragenyx, as it also delays a key test of the new ...
The Class I recall status indicates that the product poses a risk of causing serious health consequences or death if consumed ...
A recall of thousands of cases of fruits and vegetables has been issued due to potential fluid contamination—the ...
In his first 100 days as commissioner of the Food and Drug Administration, Marty Makary has made a handful of splashy ...
FDA is urging manufacturers of infant formula, baby food and children’s nutrition products to sharpen their recall ...
The U.S. Food and Drug Administration announced it had granted Gardenia Blue Interest Group’s (GBIG) color additive petition to use the color gardenia (genipin) blue ...
Agriculture Secretary Brooke Rollins and Health and Human Services Secretary Robert F. Kennedy Jr. will hold a news briefing ...
A rare metabolic condition affecting children may have to wait longer for a potential one-time treatment as Ultragenyx ...
Loss of support staff has slowed critical investigations of drug manufacturers. Little relief has materialized.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results